| 发明名称 |
USE OF AN IMMUNOREGULATORY NK CELL POPULATION FOR MONITORING THE EFFICACY OF ANTI-IL-2R ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS |
| 摘要 |
The use of CD56bright NK cell counts as a biomarker for the efficacy of anti-IL-2R antibody treatment in patients diagnosed with multiple sclerosis.
|
| 申请公布号 |
US2011053209(A1) |
申请公布日期 |
2011.03.03 |
| 申请号 |
US20100872886 |
申请日期 |
2010.08.31 |
| 申请人 |
FACET BIOTECH CORPORATION |
发明人 |
SHERIDAN, III JAMES PETER |
| 分类号 |
C12Q1/02 |
主分类号 |
C12Q1/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
